Open Access
Ann Toxicol Anal
Volume 21, Numéro 1, 2009
Page(s) 27 - 35
Publié en ligne 5 mai 2009
  1. Barbier C, Houdret N, Vittrant C, Deschildre A, Turck D. Étude du tabagisme passif par la mesure de la cotinurie en consultation de protection maternelle et infantile dans le Nord-Pas-de-Calais. Arch Pediatr. 2000; 7: 719-724. [CrossRef] [PubMed] [Google Scholar]
  2. Larramendy C, Divine C, Asnafu-Farhang S, Lagrue G. Intérêt des différents marqueurs biologiques dans l'évaluation du tabagisme. Path Biol. 2004; 52: 164-172. [CrossRef] [Google Scholar]
  3. Juchet A, Piot M, Dutau G. Tabagisme passif chez l'enfant. Encycl Méd Chir, Pédiatrie, 2002; 4-062-A-10: 1-6. [Google Scholar]
  4. Kleinman JC, Pierre MB, Madans JH, Land GH, Schramm WF. The effects of maternal smoking in fetal and infant mortality. Am J Epidemiol. 1988; 127: 274-282. [PubMed] [Google Scholar]
  5. Kline J, Stein ZA, Susser M, Warburton D. Smoking: A risk factor for spontaneous abortion. N Engl J Med. 1977; 297: 793-796. [CrossRef] [PubMed] [Google Scholar]
  6. Heffner IJ, Sherman CB, Speiser FE, Weiss ST. Clinical and environmental predictors of preterm labor. Obstet Gynecol. 1993; 81: 750-757. [PubMed] [Google Scholar]
  7. Wiszynski DF, Duffy DL, Beaty TH. Maternal cigarette smoking and oral clefts: a meta-analysis. Cleft Palate Craniofac J. 1997; 34: 206-210. [CrossRef] [PubMed] [Google Scholar]
  8. Brown RW, Hanrahan JP, Castile RG, Tager IB. Effect of maternal smoking during pregnancy on passive respiratory mechanics in early infancy. Pediatr Pulmonol. 1995; 19: 23-28. [CrossRef] [PubMed] [Google Scholar]
  9. Anderson HR, Cook DG. Passive smoking and sudden infant death syndrome: review of the epidemiological evidence. Thorax. 1997; 52: 1003-1009. [CrossRef] [PubMed] [Google Scholar]
  10. Strachan DP, Cook DG. Parental smoking and lower respiratory illness in infancy and early childhood. Thorax. 1997; 52: 905-914. [CrossRef] [PubMed] [Google Scholar]
  11. Cook DG, Strachan DP. Parental smoking and prevalence of respiratory symptoms and asthma in school age children. Thorax. 1997; 52: 1081-1094. [CrossRef] [PubMed] [Google Scholar]
  12. Janerich DT, Thomson D, Varema LR. Lung cancer and exposure to tobacco smoke in the household. N Engl J Med. 1990; 323: 632-636. [CrossRef] [PubMed] [Google Scholar]
  13. Wang FL, Love EJ, Liu N. Childhood and adolescent passive smoking and the risk of female lung cancer. Int J Epidemiol. 1994; 23: 223-230. [CrossRef] [PubMed] [Google Scholar]
  14. Smyth A, O'Hea U, Williams G. Passive smoking and impaired lung function in cystic fibrosis. Arch Dis Child. 1994; 71: 353-354. [CrossRef] [PubMed] [Google Scholar]
  15. Diguet A, Sentilhes L, Marret S, Verspyck E, Marpeau L. Quelle est la prise en charge optimale à la naissance de l'enfant exposé au tabac in utero et quelles en sont les biomarqueurs post-natals. J Gynecol Obstet Biol Reprod. 2005; 34: 458-459. [CrossRef] [Google Scholar]
  16. Hammond SK. Exposure of US workers to environnemental tobacco smoke. Environ Health Perspect. 1999; 107(2): 329-340. [CrossRef] [PubMed] [Google Scholar]
  17. Mulcahy M, Evans DS, Hammond SK, Repace JL, Byrne M. Secondhand smoke exposure and risk following the Irish smoking ban: an assessment of salivary cotinine concentrations in hotel workers and air nicotine levels in bars. Tob Control. 2005; 14(6): 384-388. [CrossRef] [PubMed] [Google Scholar]
  18. Ellingsen DG, Fladseth G, Daae HL, Gjolstad M, Kjaerheim K, Skogstad M, Olsen R, Thorud S, Molander P. Airbone exposure and biological monitoring of bar and restaurant workers before and after the introduction of a smoking ban. J Environ Monit. 2006; 8(3): 362-368. [CrossRef] [PubMed] [Google Scholar]
  19. Larsson M, Boethius G, Axelsson S, Montgomery SM. Exposure to environmental tobacco smoke and health effects among hospitality workers in Sweden before and after the implementation of a smoke free law. Scand. J Work Environ Health. 2008; 34(4): 367-377. [CrossRef] [Google Scholar]
  20. Mullally BJ, Greiner BA, Allwright S, Paul G, Perry IJ. Prevalence of smoking among bar workers prior to the republic of Ireland smokefree workplace legislation. Irish J Med. 2008; 177(4): 309-316. [CrossRef] [Google Scholar]
  21. Lin YS, Egeghy PP, Rappaport SM. Relationships between levels of volatile organic compounds in air and blood from the general population. J Expo Sci Environ Epidemiol. 2008; 18(4): 421-429. [CrossRef] [PubMed] [Google Scholar]
  22. Manini P, De Palma G, Andreoli R, Poli D, Mozzoni P, Folesani G, Mutti A, Apostoli P. Environmental and biological monitoring of benzene exposure in a cohort of italian taxi drivers. Toxicol Lett. 2006; 167: 142-151. [CrossRef] [PubMed] [Google Scholar]
  23. Dhar P. Measuring tobacoo smoke exposure : quantifying nicotine/cotinine concentration in biological samples by colorimetry, chromatography and immunoassay methods. J Pharm Biomed Anal. 2004; 35: 155-168. [CrossRef] [PubMed] [Google Scholar]
  24. Jacob N, Berny C, Boyer JC, Capolaghi B, De l'Homme G, Desch G, Garelik D, Houdret N, Le Moel G, Moulsma M, Plantin-Carrenard E. Dosage urinaire de la cotinine et des métabolites de la nicotine (Seconde partie). Ann Biol Clin. 2005; 63(5): 389-409. [Google Scholar]
  25. Akiyama Y, Arashidani K, Kawano W, Kunugita N. Urinary nicotine and its metabolites as a biomarker of exposure to environmental tobacco smoke. J UOEH. 2006; 28(3): 245-252. [PubMed] [Google Scholar]
  26. Kim H, Lim Y, Lee S, Park S, Kim C, Hong C, Shin D. Relationship between environmental tobacco smoke and urinary cotinine levels in passive smokers at their residence. J Expo Anal Environ Epidemiol. 2004; 14(1): 565-570. [Google Scholar]
  27. Schneider JM, Capolaghi B, Briançon S, Covi G, Merlin JP, Leveau PH. Le tabagisme passif chez l'enfant. Son dépistage par le dosage de la cotinine urinaire. Arch Fr Pediatr. 1993; 50: 567-571. [PubMed] [Google Scholar]
  28. Willers S, Gerhardsson L, Lundh T. Environmental tobacoo smoke (ETS) exposure in children with asthma-relation between lead and cadmium, and cotinine concentrations in urine. Resp Med. 2005; 99: 1521-1527. [CrossRef] [Google Scholar]
  29. Mansi G, Raimondi F, Pichini S, Capasso L, Sarno M, Zuccaro P, Pacifi R, Garcia-Algar O, Romano A, Paludetto R. Neonatal urinary cotinine correlates with behavioural alterations in newborns prenatally exposed to tobacco smoke. Pediatr Res. 2007; 61(2): 257-261. [CrossRef] [PubMed] [Google Scholar]
  30. Leong JW, Dore ND, Shelley K, Holt EJ, Laing A, Palmert LJ, LeSouef PN. The elimination half-life of urinary cotinine in children of tobacco-smoking mother. Pulm Pharmacol Ther. 1998; 11: 287-290. [CrossRef] [PubMed] [Google Scholar]
  31. Peterson EL, Johnson CC, Ownbry DR. Use of urinary cotinine and questionnaires in the evaluation of infant exposure to tobacco smoke in epidemiologic studies. J Clin Epidemiol. 1997; 50(8): 917-923. [CrossRef] [PubMed] [Google Scholar]
  32. Ino T, Shibuya T, Saito K, Ohshima J, Okada R. A passive smoking screening program for children. Prevent Med. 2006; 42: 427-429. [CrossRef] [Google Scholar]
  33. Aligne CA, Moss ME, Auinger P, Weitzman M. Association of pediatric dental caries with passive smoking. JAMA. 2003; 289: 1258-1264. [CrossRef] [PubMed] [Google Scholar]
  34. De Chazeron I, Daval S, Ughetto S, Richard D, Nicolay A, Lemery D, Llorca PM, Coudoré F. GC-MS determined cotinine in an epidemiological study on smoking status at delivery. Pulm Pharmacol Ther. 2008; 21: 485-488. [CrossRef] [PubMed] [Google Scholar]
  35. Dempsey D, Moore C, Deitermann D, Lewis D, Feeley B, Niedbala RS. The detection of cotinine in hydrolyzed meconium samples. Forensic Sci Int. 1999; 102: 167-171. [CrossRef] [PubMed] [Google Scholar]
  36. Ostrea EM, Knapp DK, Romero A, Montes M, Ostrea AR. Meconium analysis to assess fetal exposure to nicotine by active and passive maternal smoking. J Pediatr. 1994; 124: 471-476. [CrossRef] [PubMed] [Google Scholar]
  37. Haley NJ, Hoffman D. Analysis for nicotine and cotinine in hair to determine cigarette smoker status. Clin Chem. 1985; 31(10): 1598-1600. [PubMed] [Google Scholar]
  38. Kintz P, Ludes B, Mangin P. Evaluation of nicotine and cotinine in human hair. J Forensic Sci. 1992; 37(1): 72-76. [PubMed] [Google Scholar]
  39. Klein J, Chitayat D, Koren G. Hair analysis as a marker for fetal exposire to maternal smoking. N Engl J Med. 1993; 328(1): 66-67. [CrossRef] [Google Scholar]
  40. Eliopoulos C, Klein J, Phan MK, Greewald M, Chitayat D, Koren G. Hair concentrations of nicotine and cotinine in women and their newborn infants. JAMA. 1994; 271(8): 621-623. [CrossRef] [PubMed] [Google Scholar]
  41. Florescu A, Koren G, Klein J, Gareri J. Utilisation de la cotinine continue dans les cheveux comme marqueur d'une exposition à la fumée de tabac. Méta-analyse d'études internationales. Ann Toxicol Anal. 2005; 17(4): 253-261. [CrossRef] [EDP Sciences] [Google Scholar]
  42. Soo Quee Koh D, Choon Huat Koh G. The use of salivary biomarkers in occupational and environmental medicine. Occup Environ Med. 2007; 64: 202-210. [CrossRef] [PubMed] [Google Scholar]
  43. Wakefield M, Cameron M, Inglis G, Letcher T, Durkin S. Secondhand smoke exposure and respiratory symptoms among casino, club, and office workers in Victoria, Australia. J Occup Environ Med. 2005; 47(7): 698-703. [CrossRef] [MathSciNet] [PubMed] [Google Scholar]
  44. Deslpisheh A, Kelly Y, Brabin BJ. Passvie cigarette smoke exposure in primary school children in Liverpool. Public Health. 2006; 120: 65-69. [CrossRef] [PubMed] [Google Scholar]
  45. Jarvis MJ, Fidler J, Mindell J, Feyerabend C, West R. Assessing smoking status in children, adolescents and adults: cotinine cut-points revisited. Addiction. 2008; 103(9): 1553-1561. [CrossRef] [PubMed] [Google Scholar]
  46. Berny C, Boyer JC, Capolaghi B, De l'Homme G, Desh G, Garelik D, Hayder R, Houdret N, Jacob N, Koskas T, Lainé G, Le Moel G, Moulsma M, Plantin-Carrenard E, Venembre Ph. Les marqueurs spécifiques du tabagisme. Ann Biol Clin. 2002; 60: 263-272. [Google Scholar]
  47. Parant F, Moulsma M, Lardet G, Flourié F, Pénès MC. Métabolites urinaires de la nicotine : évaluation des immunodosages EIA "Cotinine" Microgenics et Immulite 2000 "Métabolites de la nicotine" DPC en comparaison à la colorimétrie. Immunoanal Biol Spéc. 2003; 18: 218-224. [Google Scholar]
  48. Langone JJ, Van Vunakis H. Radioimmunoassay of nicotine and cotinine, and gamma-(3-pyridyl)-gamma-oxo-N-methylbutyramide. Methods Enzymol. 1982; 84: 628-640. [CrossRef] [PubMed] [Google Scholar]
  49. Jacob N, Berny C, Boyer JC, Capolaghi B, De l'Homme G, Desch G, Garelik D, Houdret N, Le Moel G, Moulsma M, Plantin-Carrenard E. Dosage urinaire de la cotinine et des métabolites de la nicotine (première partie). Ann Biol Clin. 2005; 63(4): 397-409. [Google Scholar]